جاري التحميل

معلومات طبية المتخصصين

 

Hepatitis C

Key facts:

  • Hepatitis C is a liver disease caused by the hepatitis C virus: the virus can cause both acute and chronic hepatitis, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
  • The hepatitis C virus is a bloodborne virus and the most common modes of infection are through exposure to small quantities of blood. This may happen through injection drug use, unsafe injection practices, unsafe health care, and the transfusion of unscreened blood and blood products.
  • Globally, an estimated 71 million people have chronic hepatitis C infection.
  • A significant number of those who are chronically infected will develop cirrhosis or liver cancer.
  • Approximately 399 000 people die each year from hepatitis C, mostly from cirrhosis and hepatocellular carcinoma.
  • Antiviral medicines can cure more than 95% of persons with hepatitis C infection, thereby reducing the risk of death from liver cancer and cirrhosis, but access to diagnosis and treatment is low.
  • There is currently no vaccine for hepatitis C; however research in this area is ongoing.

 

Reference: WHO website. http://www.who.int/mediacentre/factsheets/fs164/en/

 

For more information:

Sites

http://www.who.int/features/qa/76/en/

·         What is hepatitis?

http://www.who.int/hepatitis/en/

·         Hepatitis

https://www.cdc.gov/hepatitis/hcv/index.htm

·         Viral Hepatitis

 

Publications

http://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/

·         Global hepatitis report, 2017

 

http://www.who.int/hepatitis/publications/hepatitis-c-guidelines-2016/en/

·         Guidelines for the screening, care and treatment of persons with chronic hepatitis C infection

http://www.who.int/hepatitis/publications/hepatitis-b-guidelines/en/

·         Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection

http://www.who.int/hepatitis/publications/hep-c-access-report/en/

·         Global report on access to hepatitis C treatment - Focus on overcoming barriers

http://www.who.int/mediacentre/factsheets/fs328/en/

·         Hepatitis A (Fact sheet)

http://www.who.int/mediacentre/factsheets/fs204/en/

·         Hepatitis B (Fact sheet)

http://www.who.int/mediacentre/factsheets/fs164/en/

·         Hepatitis C (Fact sheet)

http://www.who.int/mediacentre/factsheets/hepatitis-d/en/

·         Hepatitis D (Fact sheet)

http://www.who.int/mediacentre/factsheets/fs280/en/

·         Hepatitis E (Fact sheet)

 

https://www.cdc.gov/hepatitis/resources/professionals/pdfs/abctable.pdf

·         The ABCs of Hepatitis

https://www.ncbi.nlm.nih.gov/pubmed/27275625

·         The prevalence of hepatitis C virus infection in Egypt 2015: implications for future policy on prevention and treatment

https://www.ncbi.nlm.nih.gov/pubmed/26074220

·         Hepatitis C virus infection and risk factors in health-care workers at Ain Shams University Hospitals, Cairo, Egypt

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077484/

·         Known and probable risk factors for hepatitis C infection

https://www.dovepress.com/hepatitis-c-in-egypt-ndash-past-present-and-future-peer-reviewed-article-IJGM

·         Hepatitis C in Egypt – past, present, and future

https://www.hepatitisc.uw.edu/pdf/evaluation-treatment/treatment-initiation-decision/core-concept/all

·         Making a Decision on When to Initiate HCV Therapy

http://www.aphc.info/wp-content/uploads/2017/02/HCV_PHC_2017_Eliminat.pdf

·         HCV Elimination in Egypt

https://dhsprogram.com/pubs/pdf/FR313/FR313.pdf

·         Health Issues Survey, 2015

https://www.eipr.org/sites/default/files/pressreleases/pdf/hcv_treatment_in_egypt.pdf

·         HCV Treatment in Egypt Why cost remains a challenge?

http://www.egfrhep.com/2016/The%20Egyptian%20National%20HCV%20Control%20Program.pdf

·         The Egyptian National HCV Control Program Treatment outcome in the Era of DAAs

Polices &Strategies

 

http://www.who.int/hepatitis/strategy2016-2021/ghss-hep/en/

·         Global health sector strategy on viral hepatitis 2016-2021

http://www.searo.who.int/entity/hepatitis/viral-hepatitis-action-plan.pdf?ua=1

·         Regional Action Plan for Viral Hepatitisin South-East Asia: 2016-2021

http://apps.who.int/iris/bitstream/10665/183726/1/9789241509350_eng.pdf

·         Manual for the Development and Assessment of National Viral Hepatitis Plans

http://www.natap.org/2014/HCV/EGYPTIANVIRALHEPATITISACTIONPLAN%20201.pdf

·         Plan of Action for the Prevention, Care & Treatment of Viral Hepatitis, Egypt 2014-2018

 

News and Events

http://www.who.int/hepatitis/news-events/world-hepatitis-summit-2017/en/

·         World Hepatitis Summit 2017

http://www.who.int/campaigns/hepatitis-day/2017/en/

·         World Hepatitis Day, 28 July 2017

 

Media

http://www.who.int/mediacentre/events/2017/wha70/united-arab-emirates-prize/en/

·         United Arab Emirates Health Foundation Prize 2017